Last reviewed · How we verify
Atropine Sulfate 0.01% Eye Drop — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Atropine Sulfate 0.01% Eye Drop (Atropine Sulfate 0.01% Eye Drop) — Shanghai Eye Disease Prevention and Treatment Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Atropine Sulfate 0.01% Eye Drop TARGET | Atropine Sulfate 0.01% Eye Drop | Shanghai Eye Disease Prevention and Treatment Center | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Atropine Sulfate 0.01% Eye Drop CI watch — RSS
- Atropine Sulfate 0.01% Eye Drop CI watch — Atom
- Atropine Sulfate 0.01% Eye Drop CI watch — JSON
- Atropine Sulfate 0.01% Eye Drop alone — RSS
Cite this brief
Drug Landscape (2026). Atropine Sulfate 0.01% Eye Drop — Competitive Intelligence Brief. https://druglandscape.com/ci/atropine-sulfate-0-01-eye-drop. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab